CoChat

Influence of energy drink ingredients on mood and cognitive performance

Open access
Childs, Emma · 2014 · Nutrition Reviews
Cited by 48

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

Sales of energy products have grown enormously in recent years. Manufacturers claim that the products, in the form of drinks, shots, supplements, and gels, enhance physical and cognitive performance, while users believe the products promote concentration, alertness, and fun. Most of these products contain caffeine, a mild psychostimulant, as their foremost active ingredient. However, they also contain additional ingredients, e.g., carbohydrates, amino acids, herbal extracts, vitamins, and minerals, often in unspecified amounts and labeled as an "energy blend." It is not clear whether these additional ingredients provide any physical or cognitive enhancement beyond that provided by caffeine alone. This article reviews the available empirical data on the interactive effects of these ingredients and caffeine on sleep and cognitive performance and suggests objectives for future study.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/nure.12148

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Research works printed but not linked: 146

  1. Geiß, 1994, The effect of a taurine-containing drink on performance in 10 endurance-athletes, Amino Acids, 7, 45, 10.1007/BF00808445 · DOI
  2. Kennedy, 2004, A glucose-caffeine “energy drink” ameliorates subjective and performance deficits during prolonged cognitive demand, Appetite, 42, 331, 10.1016/j.appet.2004.03.001 · DOI
  3. Scholey, 2004, Cognitive and physiological effects of an “energy drink”: an evaluation of the whole drink and of glucose, caffeine and herbal flavouring fractions, Psychopharmacology, 176, 320, 10.1007/s00213-004-1935-2 · DOI · Paper page
  4. Seidl, 2000, A taurine and caffeine-containing drink stimulates cognitive performance and well-being, Amino Acids, 19, 635, 10.1007/s007260070013 · DOI · Paper page
  5. Smit, 2004, Mood and cognitive performance effects of “energy” drink constituents: caffeine, glucose and carbonation, Nutr Neurosci, 7, 127, 10.1080/10284150400003041 · DOI · Paper page
  6. Warburton, 2001, An evaluation of a caffeinated taurine drink on mood, memory and information processing in healthy volunteers without caffeine abstinence, Psychopharmacology, 158, 322, 10.1007/s002130100884 · DOI · Paper page
  7. Adan, 2010, Effects of caffeine and glucose, alone and combined, on cognitive performance, Hum Psychopharmacol, 25, 310, 10.1002/hup.1115 · DOI · Paper page
  8. Giles, 2012, Differential cognitive effects of energy drink ingredients: caffeine, taurine, and glucose, Pharmacol Biochem Behav, 102, 569, 10.1016/j.pbb.2012.07.004 · DOI · Paper page
  9. Maridakis, 2009, Sensitivity to change in cognitive performance and mood measures of energy and fatigue in response to morning caffeine alone or in combination with carbohydrate, Int J Neurosci, 119, 1239, 10.1080/00207450802333987 · DOI · Paper page
  10. Serra-Grabulosa, 2010, Glucose and caffeine effects on sustained attention: an exploratory fMRI study, Hum Psychopharmacol, 25, 543, 10.1002/hup.1150 · DOI
  11. Young, 2013, Caffeine can decrease subjective energy depending on the vehicle with which it is consumed and when it is measured, Psychopharmacology, 228, 243, 10.1007/s00213-013-3025-9 · DOI
  12. Peacock, 2013, Energy drink ingredients. Contribution of caffeine and taurine to performance outcomes, Appetite, 64, 1, 10.1016/j.appet.2012.12.021 · DOI
  13. Aggarwal, 2011, Effect of caffeine and taurine on simulated laparoscopy performed following sleep deprivation, Br J Surg, 98, 1666, 10.1002/bjs.7600 · DOI
  14. Kennedy, 2004, Improved cognitive performance in human volunteers following administration of guarana (Paullinia cupana) extract: comparison and interaction with Panax ginseng, Pharmacol Biochem Behav, 79, 401, 10.1016/j.pbb.2004.07.014 · DOI · Paper page
  15. Benton, 2002, Carbohydrate ingestion, blood glucose and mood, Neurosci Biobehav Rev, 26, 293, 10.1016/S0149-7634(02)00004-0 · DOI · Paper page
  16. Gorby, 2010, Do specific dietary constituents and supplements affect mental energy? Review of the evidence, Nutr Rev, 68, 697, 10.1111/j.1753-4887.2010.00340.x · DOI
  17. Pizziol, 1998, Effects of caffeine on glucose tolerance: a placebo-controlled study, Eur J Clin Nutr, 52, 846, 10.1038/sj.ejcn.1600657 · DOI
  18. Nobre, 2008, L-theanine, a natural constituent in tea, and its effect on mental state, Asia Pac J Clin Nutr, 17, 167
  19. D'Angelo, 1986, A double-blind, placebo-controlled clinical study on the effect of a standardized ginseng extract on psychomotor performance in healthy volunteers, J Ethnopharmacol, 16, 15, 10.1016/0378-8741(86)90063-2 · DOI
  20. Kennedy, 2001, Dose dependent changes in cognitive performance and mood following acute administration of Ginseng to healthy young volunteers, Nutr Neurosci, 4, 295, 10.1080/1028415X.2001.11747370 · DOI · Paper page
  21. Kennedy, 2002, Modulation of cognition and mood following administration of single doses of Ginkgo biloba, ginseng, and a ginkgo/ginseng combination to healthy young adults, Physiol Behav, 75, 739, 10.1016/S0031-9384(02)00665-0 · DOI
  22. Reay, 2005, Single doses of Panax ginseng (G115) reduce blood glucose levels and improve cognitive performance during sustained mental activity, J Psychopharmacol, 19, 357, 10.1177/0269881105053286 · DOI · Paper page
  23. Reay, 2006, Effects of Panax ginseng, consumed with and without glucose, on blood glucose levels and cognitive performance during sustained “mentally demanding” tasks, J Psychopharmacol, 20, 771, 10.1177/0269881106061516 · DOI · Paper page
  24. Scholey, 2002, Acute, dose-dependent cognitive effects of Ginkgo biloba, Panax ginseng and their combination in healthy young volunteers: differential interactions with cognitive demand, Hum Psychopharmacol, 17, 35, 10.1002/hup.352 · DOI · Paper page
  25. Sorensen, 1996, A double-masked study of the effects of ginseng on cognitive functions, Curr Ther Res, 57, 959, 10.1016/S0011-393X(96)80114-7 · DOI
  26. Neale, 2013, Cognitive effects of two nutraceuticals Ginseng and Bacopa benchmarked against modafinil: a review and comparison of effect sizes, Br J Clin Pharmacol, 75, 728, 10.1111/bcp.12002 · DOI · Paper page
  27. Henman, 1982, Guarana (Paullinia cupana var. sorbilis): ecological and social perspectives on an economic plant of the central Amazon basin, J Ethnopharmacol, 6, 311, 10.1016/0378-8741(82)90054-X · doi:10.1016/0378-8741(82)90054-x
  28. Haskell, 2013, Behavioural effects of compounds co-consumed in dietary forms of caffeinated plants, Nutr Res Rev, 26, 49, 10.1017/S0954422413000036 · DOI
  29. McLellan, 2012, Do energy drinks contain active components other than caffeine?, Nutr Rev, 70, 730, 10.1111/j.1753-4887.2012.00525.x · DOI · Paper page
  30. Haskell, 2007, A double-blind, placebo-controlled, multi-dose evaluation of the acute behavioural effects of guaraná in humans, J Psychopharmacol, 21, 65, 10.1177/0269881106063815 · DOI · Paper page
  31. Kennedy, 2008, Improved cognitive performance and mental fatigue following a multi-vitamin and mineral supplement with added guaraná (Paullinia cupana), Appetite, 50, 506, 10.1016/j.appet.2007.10.007 · DOI
  32. Silvestrini, 2013, Effects of a commercial product containing guarana on psychological well-being, anxiety and mood: a single-blind, placebo-controlled study in healthy subjects, J Negat Results Biomed, 12, 9, 10.1186/1477-5751-12-9 · DOI
  33. Costa Miranda, 2009, Effectiveness of guaraná (Paullinia cupana) for postradiation fatigue and depression: results of a pilot double-blind randomized study, J Altern Complement Med, 15, 431, 10.1089/acm.2008.0324 · DOI
  34. Oliveira Campos, 2011, Guaraná (Paullinia cupana) improves fatigue in breast cancer patients undergoing systemic chemotherapy, J Altern Complement Med, 17, 505, 10.1089/acm.2010.0571 · DOI · Paper page
  35. Galduróz, 1994, Acute effects of the Paulinia cupana, “Guaraná” on the cognition of normal volunteers, Sao Paulo Med J, 112, 607, 10.1590/S1516-31801994000300007 · doi:10.1590/s1516-31801994000300007
  36. Galduróz, 1996, The effects of long-term administration of guarana on the cognition of normal, elderly volunteers, Sao Paulo Med J, 114, 1073, 10.1590/S1516-31801996000100003 · doi:10.1590/s1516-31801996000100003
  37. Banderet, 1989, Treatment with tyrosine, a neurotransmitter precursor, reduces environmental stress in humans, Brain Res Bull, 22, 759, 10.1016/0361-9230(89)90096-8 · DOI · Paper page
  38. Deijen, 1994, Effect of tyrosine on cognitive function and blood pressure under stress, Brain Res Bull, 33, 319, 10.1016/0361-9230(94)90200-3 · DOI
  39. Deijen, 1999, Tyrosine improves cognitive performance and reduces blood pressure in cadets after one week of a combat training course, Brain Res Bull, 48, 203, 10.1016/S0361-9230(98)00163-4 · DOI
  40. Dollins, 1995, L-tyrosine ameliorates some effects of lower body negative pressure stress, Physiol Behav, 57, 223, 10.1016/0031-9384(94)00278-D · DOI
  41. Neri, 1995, The effects of tyrosine on cognitive performance during extended wakefulness, Aviat Space Environ Med, 66, 313
  42. Shukitt-Hale, 1996, Tyrosine administration prevents hypoxia-induced decrements in learning and memory, Physiol Behav, 59, 867, 10.1016/0031-9384(95)02107-8 · DOI
  43. Amieva, 2013, Ginkgo biloba extract and long-term cognitive decline: a 20-year follow-up population-based study, PLoS ONE, 8, e52755, 10.1371/journal.pone.0052755 · DOI
  44. Andrieu, 2003, Association of Alzheimer's disease onset with Ginkgo biloba and other symptomatic cognitive treatments in a population of women aged 75 years and older from the EPIDOS study, J Gerontol A Biol Sci Med Sci, 58, 372, 10.1093/gerona/58.4.M372 · DOI
  45. Herrschaft, 2012, Ginkgo biloba extract EGb 761(R) in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg, J Psychiatr Res, 46, 716, 10.1016/j.jpsychires.2012.03.003 · DOI · Paper page
  46. Ihl, 2010, Baseline neuropsychiatric symptoms are effect modifiers in Ginkgo biloba extract (EGb 761[R]) treatment of dementia with neuropsychiatric features. Retrospective data analyses of a randomized controlled trial, J Neurol Sci, 299, 184, 10.1016/j.jns.2010.08.033 · DOI
  47. Schneider, 2005, A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type, Curr Alzheimer Res, 2, 541, 10.2174/156720505774932287 · DOI · Paper page
  48. DeKosky, 2008, Ginkgo biloba for prevention of dementia: a randomized controlled trial, JAMA, 300, 2253, 10.1001/jama.2008.683 · DOI · Paper page
  49. Dodge, 2008, A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline, Neurology, 70, 1809, 10.1212/01.wnl.0000303814.13509.db · DOI · Paper page
  50. Vellas, 2012, Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial, Lancet Neurol, 11, 851, 10.1016/S1474-4422(12)70206-5 · DOI · Paper page
  51. Weinmann, 2010, Effects of Ginkgo biloba in dementia: systematic review and meta-analysis, BMC Geriatr, 10, 14, 10.1186/1471-2318-10-14 · DOI · Paper page
  52. Birks, 2007, Ginkgo biloba for cognitive impairment and dementia, Cochrane Database Syst Rev, 10.1002/14651858.CD003120.pub2 · DOI
  53. Canter, 2007, Ginkgo biloba is not a smart drug: an updated systematic review of randomised clinical trials testing the nootropic effects of G. biloba extracts in healthy people, Hum Psychopharmacol, 22, 265, 10.1002/hup.843 · DOI
  54. Roland, 2012, Ginkgo biloba - effect, adverse events and drug interaction, Tidsskr Nor Laegeforen, 132, 956, 10.4045/tidsskr.11.0780 · DOI
  55. Kennedy, 2007, Acute cognitive effects of standardised Ginkgo biloba extract complexed with phosphatidylserine, Hum Psychopharmacol, 22, 199, 10.1002/hup.837 · DOI
  56. Rigney, 1999, The effects of acute doses of standardized Ginkgo biloba extract on memory and psychomotor performance in volunteers, Phytother Res, 13, 408, 10.1002/(SICI)1099-1573(199908/09)13:5<408::AID-PTR530>3.0.CO;2-C · DOI · Paper page
  57. Kennedy, 2000, The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers, Psychopharmacology, 151, 416, 10.1007/s002130000501 · DOI · Paper page
  58. Kennedy, 2007, Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers, Hum Psychopharmacol, 22, 559, 10.1002/hup.885 · DOI · Paper page
  59. Itil, 1996, Central nervous system effects of Ginkgo biloba, a plant extract, Am J Ther, 3, 63, 10.1097/00045391-199601000-00009 · DOI
  60. Kennedy, 2003, Electroencephalograph effects of single doses of Ginkgo biloba and Panax ginseng in healthy young volunteers, Pharmacol Biochem Behav, 75, 701, 10.1016/S0091-3057(03)00120-5 · DOI
  61. Ozgoli, 2009, A randomized, placebo-controlled trial of Ginkgo biloba L. in treatment of premenstrual syndrome, J Altern Complement Med, 15, 845, 10.1089/acm.2008.0493 · doi:10.1089/acm.2008.0493
  62. Hartley, 2003, Effects on cognition and mood in postmenopausal women of 1-week treatment with Ginkgo biloba, Pharmacol Biochem Behav, 75, 711, 10.1016/S0091-3057(03)00123-0 · DOI
  63. Cockle, 2000, The effects of Ginkgo biloba extract (LI 1370) supplementation on activities of daily living in free living older volunteers: a questionnaire survey, Hum Psychopharmacol, 15, 227, 10.1002/1099-1077(200006)15:4<227::AID-HUP208>3.0.CO;2-M · DOI
  64. Soholm, 1998, Clinical improvement of memory and other cognitive functions by Ginkgo biloba: review of relevant literature, Adv Ther, 15, 54
  65. Stough, 2001, Neuropsychological changes after 30-day Ginkgo biloba administration in healthy participants, Int J Neuropsychopharmacol, 4, 131, 10.1017/S1461145701002292 · DOI · Paper page
  66. Kaschel, 2009, Ginkgo biloba: specificity of neuropsychological improvement - a selective review in search of differential effects, Hum Psychopharmacol, 24, 345, 10.1002/hup.1037 · DOI · Paper page
  67. Zadoyan, 2012, Effect of Ginkgo biloba special extract EGb 761(R) on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers, Eur J Clin Pharmacol, 68, 553, 10.1007/s00228-011-1174-5 · DOI
  68. Baggott, 2013, Psychopharmacology of theobromine in healthy volunteers, Psychopharmacology, 228, 109, 10.1007/s00213-013-3021-0 · DOI
  69. Mumford, 1994, Discriminative stimulus and subjective effects of theobromine and caffeine in humans, Psychopharmacology, 115, 1, 10.1007/BF02244744 · DOI
  70. Smit, 2004, Methylxanthines are the psycho-pharmacologically active constituents of chocolate, Psychopharmacology, 176, 412, 10.1007/s00213-004-1898-3 · DOI
  71. Bartel, 1992, Effects of single and repeated doses of theophylline on aspects of performance, electrophysiology and subjective assessments in healthy human subjects, Psychopharmacology, 106, 90, 10.1007/BF02253594 · DOI
  72. Tiplady, 1990, A comparison of the CNS effects of enprofylline and theophylline in healthy subjects assessed by performance testing and subjective measures, Br J Clin Pharmacol, 30, 55, 10.1111/j.1365-2125.1990.tb03743.x · DOI
  73. Yu, 1991, A comparison of the central nervous system effects of caffeine and theophylline in elderly subjects, Br J Clin Pharmacol, 32, 341, 10.1111/j.1365-2125.1991.tb03909.x · DOI
  74. Nehlig, 2013, The neuroprotective effects of cocoa flavanol and its influence on cognitive performance, Br J Clin Pharmacol, 75, 716, 10.1111/j.1365-2125.2012.04378.x · DOI · Paper page
  75. Macready, 2009, Flavonoids and cognitive function: a review of human randomized controlled trial studies and recommendations for future studies, Genes Nutr, 4, 227, 10.1007/s12263-009-0135-4 · DOI · Paper page
  76. Young, 2007, Folate and depression - a neglected problem, J Psychiatry Neurosci, 32, 80
  77. Young, 1989, Folic acid and psychopathology, Prog Neuropsychopharmacol Biol Psychiatry, 13, 841, 10.1016/0278-5846(89)90037-7 · DOI
  78. Falkingham, 2010, The effects of oral iron supplementation on cognition in older children and adults: a systematic review and meta-analysis, Nutr J, 9, 4, 10.1186/1475-2891-9-4 · DOI · Paper page
  79. Vinod Kumar, 2008, Trial using multiple micronutrient food supplement and its effect on cognition, Indian J Pediatr, 75, 671, 10.1007/s12098-008-0127-1 · DOI
  80. Bryan, 2004, Associations between dietary intake of folate and vitamins B-12 and B-6 and self-reported cognitive function and psychological well-being in Australian men and women in midlife, J Nutr Health Aging, 8, 226
  81. Deijen, 1992, Vitamin B-6 supplementation in elderly men: effects on mood, memory, performance and mental effort, Psychopharmacology, 109, 489, 10.1007/BF02247729 · DOI
  82. Bryan, 2002, Short-term folate, vitamin B-12 or vitamin B-6 supplementation slightly affects memory performance but not mood in women of various ages, J Nutr, 132, 1345, 10.1093/jn/132.6.1345 · DOI · Paper page
  83. Haskell, 2010, Effects of a multi-vitamin/mineral supplement on cognitive function and fatigue during extended multi-tasking, Hum Psychopharmacol, 25, 448, 10.1002/hup.1144 · DOI · Paper page
  84. Malouf, 2008, Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people, Cochrane Database Syst Rev, 4, 10.1002/14651858.CD004514.pub2 · DOI · Paper page
  85. Zhang, 2011, Vitamin C provision improves mood in acutely hospitalized patients, Nutrition, 27, 530, 10.1016/j.nut.2010.05.016 · DOI
  86. Chui, 2008, Antioxidant vitamins reduce acute meal-induced memory deficits in adults with type 2 diabetes, Nutr Res, 28, 423, 10.1016/j.nutres.2008.03.016 · DOI
  87. Dixon, 1997, Effects of CDP-choline treatment on neurobehavioral deficits after TBI and on hippocampal and neocortical acetylcholine release, J Neurotrauma, 14, 161, 10.1089/neu.1997.14.161 · DOI · Paper page
  88. Petkov, 1990, Changes in brain biogenic monoamines induced by the nootropic drugs adafenoxate and meclofenoxate and by citicholine (experiments on rats), Gen Pharmacol, 21, 71, 10.1016/0306-3623(90)90598-G · DOI
  89. Alvarez, 1997, Citicoline improves memory performance in elderly subjects, Methods Find Exp Clin Pharmacol, 19, 201
  90. Di Trapani, 1991, Citicoline in the treatment of cognitive and behavioral disorders in pathologic senile decline, Clin Ter, 137, 403
  91. Spiers, 1996, Citicoline improves verbal memory in aging, Arch Neurol, 53, 441, 10.1001/archneur.1996.00550050071026 · DOI · Paper page
  92. Fioravanti, 2006, Citicoline (Cognizin) in the treatment of cognitive impairment, Clin Interv Aging, 1, 247, 10.2147/ciia.2006.1.3.247 · DOI
  93. Bruce, 2012, Improvements in quantitative EEG following consumption of a natural citicoline-enhanced beverage, Int J Food Sci Nutr, 63, 421, 10.3109/09637486.2011.632623 · DOI
  94. Silveri, 2008, Citicoline enhances frontal lobe bioenergetics as measured by phosphorus magnetic resonance spectroscopy, NMR Biomed, 21, 1066, 10.1002/nbm.1281 · DOI
  95. Cynober, 2007, Pharmacokinetics of arginine and related amino acids, J Nutr, 137, 1646S, 10.1093/jn/137.6.1646S · DOI
  96. McConell, 2007, Effects of L-arginine supplementation on exercise metabolism, Curr Opin Clin Nutr Metab Care, 10, 46, 10.1097/MCO.0b013e32801162fa · DOI · Paper page
  97. Paul, 2003, Prevention of picrotoxin convulsions-induced learning and memory impairment by nitric oxide increasing dose of L-arginine in rats, Pharmacol Biochem Behav, 75, 329, 10.1016/S0091-3057(03)00084-4 · DOI
  98. Paul, 2005, A reversal by L-arginine and sodium nitroprusside of ageing-induced memory impairment in rats by increasing nitric oxide concentration in the hippocampus, Indian J Physiol Pharmacol, 49, 179
  99. Ohtsuka, 2000, Effect of oral administration of L-arginine on senile dementia, Am J Med, 108, 439, 10.1016/S0002-9343(99)00396-4 · DOI
  100. Yi, 2009, L-arginine and Alzheimer's disease, Int J Clin Exp Pathol, 2, 211
  101. Khan, 2013, Tea and health: studies in humans, Curr Pharm Des, 19, 6141, 10.2174/1381612811319340008 · DOI · Paper page
  102. Song, 2012, Tea and cognitive health in late life: current evidence and future directions, J Nutr Health Aging, 16, 31, 10.1007/s12603-011-0139-9 · DOI · Paper page
  103. Malaguarnera, 2012, Carnitine derivatives: clinical usefulness, Curr Opin Gastroenterol, 28, 166, 10.1097/MOG.0b013e3283505a3b · DOI
  104. Malaguarnera, 2013, Acetyl-L-carnitine in hepatic encephalopathy, Metab Brain Dis, 28, 193, 10.1007/s11011-013-9376-4 · DOI
  105. Tempesta, 1987, L-acetylcarnitine in depressed elderly subjects. A cross-over study versus placebo, Drugs Exp Clin Res, 13, 417
  106. Birdsall, 1998, 5-Hydroxytryptophan: a clinically-effective serotonin precursor, Altern Med Rev, 3, 271
  107. Meyers, 2000, Use of neurotransmitter precursors for treatment of depression, Altern Med Rev, 5, 64
  108. Zmilacher, 1988, L-5-hydroxytryptophan alone and in combination with a peripheral decarboxylase inhibitor in the treatment of depression, Neuropsychobiology, 20, 28, 10.1159/000118469 · DOI
  109. Lynn-Bullock, 2004, The effect of oral 5-HTP administration on 5-HTP and 5-HT immunoreactivity in monoaminergic brain regions of rats, J Chem Neuroanat, 27, 129, 10.1016/j.jchemneu.2004.02.003 · DOI
  110. Okada, 2009, Immunogenetic risk and protective factors for the development of L-tryptophan-associated eosinophilia-myalgia syndrome and associated symptoms, Arthritis Rheum, 61, 1305, 10.1002/art.24460 · doi:10.1002/art.24460
  111. Turner, 2006, Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan, Pharmacol Ther, 109, 325, 10.1016/j.pharmthera.2005.06.004 · DOI · Paper page
  112. Gendle, 2010, Oral administration of 5-hydroxytryptophan (5-HTP) impairs decision making under ambiguity but not under risk: evidence from the Iowa Gambling Task, Hum Psychopharmacol, 25, 491, 10.1002/hup.1139 · DOI
  113. Gijsman, 2002, Placebo-controlled comparison of three dose-regimens of 5-hydroxytryptophan challenge test in healthy volunteers, J Clin Psychopharmacol, 22, 183, 10.1097/00004714-200204000-00012 · DOI · Paper page
  114. Cunliffe, 1998, A placebo-controlled investigation of the effects of tryptophan or placebo on subjective and objective measures of fatigue, Eur J Clin Nutr, 52, 425, 10.1038/sj.ejcn.1600581 · DOI
  115. Gendle, 2013, Effects of oral 5-hydroxytryptophan on a standardized planning task: insight into possible dopamine/serotonin interactions in the forebrain, Hum Psychopharmacol, 28, 270, 10.1002/hup.2314 · DOI
  116. Alves, 1995, Effects of caffeine and tryptophan on rectal temperature, metabolism, total exercise time, rate of perceived exertion and heart rate, Braz J Med Biol Res, 28, 705
  117. Kasper, 2008, Efficacy of St. John's wort extract WS 5570 in acute treatment of mild depression: a reanalysis of data from controlled clinical trials, Eur Arch Psychiatry Clin Neurosci, 258, 59, 10.1007/s00406-007-0779-2 · DOI
  118. Linde, 1996, St John's wort for depression - an overview and meta-analysis of randomised clinical trials, BMJ, 313, 253, 10.1136/bmj.313.7052.253 · DOI · Paper page
  119. Brenner, 2000, Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study, Clin Ther, 22, 411, 10.1016/S0149-2918(00)89010-4 · DOI · Paper page
  120. Schrader, 2000, Equivalence of St John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression, Int Clin Psychopharmacol, 15, 61, 10.1097/00004850-200015020-00001 · DOI · Paper page
  121. Wheatley, 1997, LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients - a controlled 6-week clinical trial, Pharmacopsychiatry, 30, 77, 10.1055/s-2007-979523 · DOI
  122. Woelk, 2000, Comparison of St John's wort and imipramine for treating depression: randomised controlled trial, BMJ, 321, 536, 10.1136/bmj.321.7260.536 · DOI · Paper page
  123. Ernst, 1999, Second thoughts about safety of St John's wort, Lancet, 354, 2014, 10.1016/S0140-6736(99)00418-3 · DOI · Paper page
  124. Russo, 2014, Hypericum perforatum: Pharmacokinetic, Mechanism of Action, Tolerability, and Clinical Drug-Drug Interactions, Phytother Res, 28, 643, 10.1002/ptr.5050 · DOI · Paper page
  125. Butterweck, 2003, Mechanism of action of St John's wort in depression: what is known?, CNS Drugs, 17, 539, 10.2165/00023210-200317080-00001 · DOI · Paper page
  126. Chatterjee, 1998, Hyperforin as a possible antidepressant component of Hypericum extracts, Life Sci, 63, 499, 10.1016/S0024-3205(98)00299-9 · DOI · Paper page
  127. Chatterjee, 1998, Antidepressant activity of Hypericum perforatum and hyperforin: the neglected possibility, Pharmacopsychiatry, 31, 7, 10.1055/s-2007-979340 · DOI · Paper page
  128. Muller, 1997, Effects of Hypericum extract (LI 160) in biochemical models of antidepressant activity, Pharmacopsychiatry, 30, 102, 10.1055/s-2007-979528 · DOI · Paper page
  129. Wonnemann, 2000, Inhibition of synaptosomal uptake of 3H-L-glutamate and 3H-GABA by hyperforin, a major constituent of St. John's Wort: the role of amiloride sensitive sodium conductive pathways, Neuropsychopharmacology, 23, 188, 10.1016/S0893-133X(00)00102-0 · DOI
  130. Ellis, 2001, An investigation into the acute nootropic effects of Hypericum perforatum L. (St. John's Wort) in healthy human volunteers, Behav Pharmacol, 12, 173, 10.1097/00008877-200105000-00003 · DOI
  131. Timoshanko, 2001, A preliminary investigation on the acute pharmacodynamic effects of hypericum on cognitive and psychomotor performance, Behav Pharmacol, 12, 635, 10.1097/00008877-200112000-00008 · DOI
  132. Arold, 2005, No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract, Planta Med, 71, 331, 10.1055/s-2005-864099 · DOI · Paper page
  133. Charney, 1985, Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment, Arch Gen Psychiatry, 42, 458, 10.1001/archpsyc.1985.01790280040004 · DOI
  134. Halliday, 1994, The effect of d-amphetamine, clonidine, and yohimbine on human information processing, Psychophysiology, 31, 331, 10.1111/j.1469-8986.1994.tb02441.x · DOI · Paper page
  135. Mizuki, 1996, Differential effects of noradrenergic drugs on anxiety and arousal in healthy volunteers with high and low anxiety, Prog Neuropsychopharmacol Biol Psychiatry, 20, 1353, 10.1016/S0278-5846(96)00131-5 · DOI
  136. Kearney, 2010, Adverse drug events associated with yohimbine-containing products: a retrospective review of the California Poison Control System reported cases, Ann Pharmacother, 44, 1022, 10.1345/aph.1P060 · DOI
  137. Heck, 2007, Yerba Mate tea (Ilex paraguariensis): a comprehensive review on chemistry, health implications, and technological considerations, J Food Sci, 72, R138, 10.1111/j.1750-3841.2007.00535.x · DOI · Paper page
  138. Bonoczk, 2002, Vinpocetine increases cerebral blood flow and oxygenation in stroke patients: a near infrared spectroscopy and transcranial Doppler study, Eur J Ultrasound, 15, 85, 10.1016/S0929-8266(02)00006-X · DOI
  139. Patyar, 2011, Role of vinpocetine in cerebrovascular diseases, Pharmacological Reports, 63, 618, 10.1016/S1734-1140(11)70574-6 · DOI
  140. Brown, 2013, Toxicity from bodybuilding supplements and recreational use of products containing 1,3-dimethylamylamine, Med J Aust, 198, 414, 10.5694/mja12.11167 · doi:10.5694/mja12.11167
  141. Eliason, 2012, Case reports: death of active duty soldiers following ingestion of dietary supplements containing 1,3-dimethylamylamine (DMAA), Mil Med, 177, 1455, 10.7205/MILMED-D-12-00265 · DOI · Paper page
  142. Lieberman, 2006, Mental energy: assessing the cognition dimension, Nutr Rev, 64, S10, 10.1111/j.1753-4887.2006.tb00252.x · DOI
  143. O'Connor, 2006, Mental energy: assessing the mood dimension, Nutr Rev, 64, S7, 10.1111/j.1753-4887.2006.tb00256.x · DOI · Paper page
  144. O'Connor, 2006, Mental energy: developing a model for examining nutrition-related claims, Nutr Rev, 64, S2, 10.1111/j.1753-4887.2006.tb00255.x · DOI
  145. Arria, 2011, Energy drink consumption and increased risk for alcohol dependence, Alcohol Clin Exp Res, 35, 365, 10.1111/j.1530-0277.2010.01352.x · DOI · Paper page
  146. Arria, 2010, Increased alcohol consumption, nonmedical prescription drug use, and illicit drug use are associated with energy drink consumption among college students, J Addict Med, 4, 74, 10.1097/ADM.0b013e3181aa8dd4 · DOI · Paper page

Cited by

See all 48

Metadata

Authors
Childs, E.
Venue
Nutrition Reviews
Published
2014-10
Volume
72
Pages
48-59
ISSN
0029-6643 (ISSN-L)
OpenAlex
W2079261072
Cited by
48
References
30
FWCI
3.68
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Influence of energy drink ingredients on mood and cognitive performance. https://app.cochat.ai/papers/10.1111/nure.12148
The paper
Childs, E. (2014). Influence of energy drink ingredients on mood and cognitive performance. Nutrition Reviews. https://doi.org/10.1111/nure.12148

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.